tailieunhanh - Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

Oxaliplatin is a chemotherapy agent active against digestive tumors. Peripheral neuropathy is one of the most important dose-limiting toxicity of this drug. It occurs in around 60–80% of the patients, and 15% of them develop severe neuropathy. The pathophysiology of oxaliplatin neurotoxicity remains unclear. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN